Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Neurosurgery|March 2, 2011
Whole genome analysis from microdissected tissue revealed adult supratentorial grade II-III gliomas are divided into clinically relevant subgroups by genetic profileYuichi Hirose, Hikaru Sasaki, Tomoru Miwa, et al.Cancer Science|May 20, 2016
World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineagesNatsuki Hattori, Yuichi Hirose, Hikaru Sasaki, et al.Oncotarget|November 22, 2017
Remote intracranial recurrence of IDH mutant gliomas is associated with TP53 mutations and an 8q gainShunsuke Nakae, Takema Kato, Kazuhiro Murayama, et al.Frontiers in Neuroscience|May 23, 2022
Intraoperative Real-Time Near-Infrared Image-Guided Surgery to Identify Intracranial Meningiomas via MicroscopeJun Muto, Yutaka Mine, Yuya Nishiyama, et al.Journal of Neuro-Oncology|November 13, 2016
Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parametersShunsuke Nakae, Kazuhiro Murayama, Hikaru Sasaki, et al.Plos One|November 13, 2015
PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant GliomasShunsuke Nakae, Hikaru Sasaki, Saeko Hayashi, et al.Neurologia Medico-Chirurgica|June 3, 2021
Myoinositol to Total Choline Ratio in Glioblastomas as a Potential Prognostic Factor in Preoperative Magnetic Resonance SpectroscopyMasanobu Kumon, Shunsuke Nakae, Kazuhiro Murayama, et al.Neurosurgical Focus: Video|October 26, 2022
Utility of intraoperative real-time near-infrared fluorescence surgery for spinal schwannomaJun Muto, Yutaka Mine, Sota Nagai, et al.Neurosurgery|December 14, 2019
The Correlation of Fluorescence of Protoporphyrinogen IX and Status of Isocitrate Dehydrogenase in GliomasShigeo Ohba, Kazuhiro Murayama, Kiyonori Kuwahara, et al.Current Oncology (Toronto, Ont.)|February 12, 2021
Rationale and Design of BeatNF2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Bevacizumab in Patients with Neurofibromatosis Type 2 Related Vestibular SchwannomaMasazumi Fujii, Masao Kobayakawa, Kiyoshi Saito, et al.Pageof 9